Developing an approach to assessing the political feasibility of global collective action and an international agreement on antimicrobial resistance View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Susan Rogers Van Katwyk, Marie Évelyne Danik, Ioana Pantis, Rachel Smith, John-Arne Røttingen, Steven J. Hoffman

ABSTRACT

Background: Antimicrobial resistance (AMR) is a global issue. International trade, travel, agricultural practices, and environmental contamination all make it possible for resistant microbes to cross national borders. Global collective action is needed in the form of an international agreement or other mechanism that brings states together at the negotiation table and commits them to adopt or implement policies to limit the spread of resistant microorganisms. This article describes an approach to assessing whether political and stakeholder interests can align to commit to tackling AMR. Methods: Two dimensions affecting political feasibility were selected and compared across 82 countries: 1) states' global influence and 2) self-interest in addressing AMR. World Bank GDP ranking was used as a proxy for global influence, while human antibiotic consumption (10-year percent change) was used as a proxy for self-interest in addressing AMR. We used these data to outline a typology of four country archetypes, and discuss how these archetypes can be used to understand whether a proposed agreement may have sufficient support to be politically feasible. Results: Four types of countries exist within our proposed typology: 1) wealthy countries who have the expertise and financial resources to push for global collective action on AMR, 2) wealthy countries who need to act on AMR, 3) countries who require external assistance to act on AMR, and 4) neutral countries who may support action where applicable. Any international agreement will require substantial support from countries of the first type to lead global action, and from countries of the second type who have large increasing antimicrobial consumption levels. A large number of barriers exist that could derail efforts towards global collective action on AMR; issues of capacity, infrastructure, regulation, and stakeholder interests will need to be addressed in coordination with other actors to achieve an agreement on AMR. Conclusions: Achieving a global agreement on access, conservation, and innovation - the three pillars of AMR - will not be easy. However, smaller core groups of interested Initiator and Pivotal Countries could develop policy and resolve many issues. If highly influential countries take the lead, agreements could then be scaled up to achieve global action. More... »

PAGES

20

References to SciGraph publications

  • 2006-03. A macroeconomic approach to evaluating policies to contain antimicrobial resistance in APPLIED HEALTH ECONOMICS AND HEALTH POLICY
  • 1991. International Federation of Pharmaceutical Manufacturers Associations in IMPROVING DRUG SAFETY — A JOINT RESPONSIBILITY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s41256-016-0020-9

    DOI

    http://dx.doi.org/10.1186/s41256-016-0020-9

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1029953235

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/29202068


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1606", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Political Science", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/16", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Studies in Human Society", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "University of Ottawa", 
              "id": "https://www.grid.ac/institutes/grid.28046.38", 
              "name": [
                "Global Strategy Lab, Centre for Health Law, Policy & Ethics, Faculty of Law, University of Ottawa, Ottawa, Canada", 
                "School of Epidemiology, Public Health, and Preventive Medicine, University of Ottawa, Ottawa, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rogers Van Katwyk", 
            "givenName": "Susan", 
            "id": "sg:person.011661644235.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011661644235.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Ottawa", 
              "id": "https://www.grid.ac/institutes/grid.28046.38", 
              "name": [
                "Global Strategy Lab, Centre for Health Law, Policy & Ethics, Faculty of Law, University of Ottawa, Ottawa, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Danik", 
            "givenName": "Marie \u00c9velyne", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Ottawa", 
              "id": "https://www.grid.ac/institutes/grid.28046.38", 
              "name": [
                "Global Strategy Lab, Centre for Health Law, Policy & Ethics, Faculty of Law, University of Ottawa, Ottawa, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pantis", 
            "givenName": "Ioana", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Ottawa", 
              "id": "https://www.grid.ac/institutes/grid.28046.38", 
              "name": [
                "Global Strategy Lab, Centre for Health Law, Policy & Ethics, Faculty of Law, University of Ottawa, Ottawa, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Smith", 
            "givenName": "Rachel", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Harvard University", 
              "id": "https://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Global Strategy Lab, Centre for Health Law, Policy & Ethics, Faculty of Law, University of Ottawa, Ottawa, Canada", 
                "Division of Infection Control & Environmental Health, Norwegian Institute of Public Health, Oslo, Norway", 
                "Department of Health and Society, University of Oslo, Oslo, Norway", 
                "Department of Global Health & Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "R\u00f8ttingen", 
            "givenName": "John-Arne", 
            "id": "sg:person.01207073626.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207073626.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Harvard University", 
              "id": "https://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Global Strategy Lab, Centre for Health Law, Policy & Ethics, Faculty of Law, University of Ottawa, Ottawa, Canada", 
                "Department of Clinical Epidemiology & Biostatistics and McMaster Health Forum, McMaster University, Hamilton, ON, Canada", 
                "Department of Global Health & Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hoffman", 
            "givenName": "Steven J.", 
            "id": "sg:person.01132037561.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132037561.53"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1111/jlme.12272", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000410078"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12272", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000410078"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2471/blt.15.153171", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008045128"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-642-61250-3_4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010599777", 
              "https://doi.org/10.1007/978-3-642-61250-3_4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1017/s0020818300027697", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012806935"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12253", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014964713"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12253", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014964713"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1371/journal.pmed.0030001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017489919"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1371/journal.pmed.0030001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017489919"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00148365-200605010-00007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019763979", 
              "https://doi.org/10.2165/00148365-200605010-00007"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12277", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022284653"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12277", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022284653"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12269", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025989615"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12269", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025989615"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12275", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028362199"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12275", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028362199"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3201/eid0402.980204", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029666390"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12268", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030271475"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/jlme.12268", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030271475"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.idc.2011.02.002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032659367"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2471/blt.15.158998", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034639063"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(15)00668-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043844175"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(15)00470-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044110610"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1473-3099(16)30341-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045408017"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/175797590200900401", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1075281027"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/175797590200900401", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1075281027"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/003335491212700103", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1078511221"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/003335491212700103", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1078511221"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2016-12", 
        "datePublishedReg": "2016-12-01", 
        "description": "Background: Antimicrobial resistance (AMR) is a global issue. International trade, travel, agricultural practices, and environmental contamination all make it possible for resistant microbes to cross national borders. Global collective action is needed in the form of an international agreement or other mechanism that brings states together at the negotiation table and commits them to adopt or implement policies to limit the spread of resistant microorganisms. This article describes an approach to assessing whether political and stakeholder interests can align to commit to tackling AMR.\nMethods: Two dimensions affecting political feasibility were selected and compared across 82 countries: 1) states' global influence and 2) self-interest in addressing AMR. World Bank GDP ranking was used as a proxy for global influence, while human antibiotic consumption (10-year percent change) was used as a proxy for self-interest in addressing AMR. We used these data to outline a typology of four country archetypes, and discuss how these archetypes can be used to understand whether a proposed agreement may have sufficient support to be politically feasible.\nResults: Four types of countries exist within our proposed typology: 1) wealthy countries who have the expertise and financial resources to push for global collective action on AMR, 2) wealthy countries who need to act on AMR, 3) countries who require external assistance to act on AMR, and 4) neutral countries who may support action where applicable. Any international agreement will require substantial support from countries of the first type to lead global action, and from countries of the second type who have large increasing antimicrobial consumption levels. A large number of barriers exist that could derail efforts towards global collective action on AMR; issues of capacity, infrastructure, regulation, and stakeholder interests will need to be addressed in coordination with other actors to achieve an agreement on AMR.\nConclusions: Achieving a global agreement on access, conservation, and innovation - the three pillars of AMR - will not be easy. However, smaller core groups of interested Initiator and Pivotal Countries could develop policy and resolve many issues. If highly influential countries take the lead, agreements could then be scaled up to achieve global action.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1186/s41256-016-0020-9", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.4639944", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1158561", 
            "issn": [
              "2397-0642"
            ], 
            "name": "Global Health Research and Policy", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "1"
          }
        ], 
        "name": "Developing an approach to assessing the political feasibility of global collective action and an international agreement on antimicrobial resistance", 
        "pagination": "20", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "8eb185d40be34b140c0fa8a43972ebb08454d1d6f03d9a82d6305c5ab5f4edfd"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "29202068"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "101705789"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s41256-016-0020-9"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1029953235"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s41256-016-0020-9", 
          "https://app.dimensions.ai/details/publication/pub.1029953235"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T12:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70032_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1186%2Fs41256-016-0020-9"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s41256-016-0020-9'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s41256-016-0020-9'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s41256-016-0020-9'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s41256-016-0020-9'


     

    This table displays all metadata directly associated to this object as RDF triples.

    169 TRIPLES      21 PREDICATES      48 URIs      21 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s41256-016-0020-9 schema:about anzsrc-for:16
    2 anzsrc-for:1606
    3 schema:author N527c681d1c6347e2bfd51a305d68ca28
    4 schema:citation sg:pub.10.1007/978-3-642-61250-3_4
    5 sg:pub.10.2165/00148365-200605010-00007
    6 https://doi.org/10.1016/j.idc.2011.02.002
    7 https://doi.org/10.1016/s0140-6736(15)00470-5
    8 https://doi.org/10.1016/s0140-6736(15)00668-6
    9 https://doi.org/10.1016/s1473-3099(16)30341-3
    10 https://doi.org/10.1017/s0020818300027697
    11 https://doi.org/10.1111/jlme.12253
    12 https://doi.org/10.1111/jlme.12268
    13 https://doi.org/10.1111/jlme.12269
    14 https://doi.org/10.1111/jlme.12272
    15 https://doi.org/10.1111/jlme.12275
    16 https://doi.org/10.1111/jlme.12277
    17 https://doi.org/10.1177/003335491212700103
    18 https://doi.org/10.1177/175797590200900401
    19 https://doi.org/10.1371/journal.pmed.0030001
    20 https://doi.org/10.2471/blt.15.153171
    21 https://doi.org/10.2471/blt.15.158998
    22 https://doi.org/10.3201/eid0402.980204
    23 schema:datePublished 2016-12
    24 schema:datePublishedReg 2016-12-01
    25 schema:description Background: Antimicrobial resistance (AMR) is a global issue. International trade, travel, agricultural practices, and environmental contamination all make it possible for resistant microbes to cross national borders. Global collective action is needed in the form of an international agreement or other mechanism that brings states together at the negotiation table and commits them to adopt or implement policies to limit the spread of resistant microorganisms. This article describes an approach to assessing whether political and stakeholder interests can align to commit to tackling AMR. Methods: Two dimensions affecting political feasibility were selected and compared across 82 countries: 1) states' global influence and 2) self-interest in addressing AMR. World Bank GDP ranking was used as a proxy for global influence, while human antibiotic consumption (10-year percent change) was used as a proxy for self-interest in addressing AMR. We used these data to outline a typology of four country archetypes, and discuss how these archetypes can be used to understand whether a proposed agreement may have sufficient support to be politically feasible. Results: Four types of countries exist within our proposed typology: 1) wealthy countries who have the expertise and financial resources to push for global collective action on AMR, 2) wealthy countries who need to act on AMR, 3) countries who require external assistance to act on AMR, and 4) neutral countries who may support action where applicable. Any international agreement will require substantial support from countries of the first type to lead global action, and from countries of the second type who have large increasing antimicrobial consumption levels. A large number of barriers exist that could derail efforts towards global collective action on AMR; issues of capacity, infrastructure, regulation, and stakeholder interests will need to be addressed in coordination with other actors to achieve an agreement on AMR. Conclusions: Achieving a global agreement on access, conservation, and innovation - the three pillars of AMR - will not be easy. However, smaller core groups of interested Initiator and Pivotal Countries could develop policy and resolve many issues. If highly influential countries take the lead, agreements could then be scaled up to achieve global action.
    26 schema:genre research_article
    27 schema:inLanguage en
    28 schema:isAccessibleForFree true
    29 schema:isPartOf N2479701527154af98d8e9fa394ff8334
    30 N49582eaa07f64f6a87640fc150b18b24
    31 sg:journal.1158561
    32 schema:name Developing an approach to assessing the political feasibility of global collective action and an international agreement on antimicrobial resistance
    33 schema:pagination 20
    34 schema:productId N3240ac967dce4429b17cdbe3df67dbe1
    35 N9e24352088564ee68cb375554d8b6bb1
    36 Nb1560380ada54f7e8919574c28a603b2
    37 Nd55d5a1d8eff4dfb9a40e73634e35ce8
    38 Nd59706caf9ab4677b3113e6824aa1ae4
    39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029953235
    40 https://doi.org/10.1186/s41256-016-0020-9
    41 schema:sdDatePublished 2019-04-11T12:37
    42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    43 schema:sdPublisher N9996eb34bfb348d2b3cd42c4dff044e5
    44 schema:url https://link.springer.com/10.1186%2Fs41256-016-0020-9
    45 sgo:license sg:explorer/license/
    46 sgo:sdDataset articles
    47 rdf:type schema:ScholarlyArticle
    48 N002c796db21a4c10aa1523dd72e7463f rdf:first Nc04ce3c9811c464da929624cc47d98de
    49 rdf:rest N905fefd2e129415fabbc8d8a38bd647c
    50 N2479701527154af98d8e9fa394ff8334 schema:volumeNumber 1
    51 rdf:type schema:PublicationVolume
    52 N3240ac967dce4429b17cdbe3df67dbe1 schema:name pubmed_id
    53 schema:value 29202068
    54 rdf:type schema:PropertyValue
    55 N39668d3f746a40e39f2c28c07780029f rdf:first Nca7760f7b148466599bf0bb402359d34
    56 rdf:rest N5dd6fa2d1cea47e4ab2958a3a12a2a8b
    57 N49582eaa07f64f6a87640fc150b18b24 schema:issueNumber 1
    58 rdf:type schema:PublicationIssue
    59 N527c681d1c6347e2bfd51a305d68ca28 rdf:first sg:person.011661644235.07
    60 rdf:rest N39668d3f746a40e39f2c28c07780029f
    61 N5dd6fa2d1cea47e4ab2958a3a12a2a8b rdf:first Nc2fb8aa82d46407a873438beb37d608c
    62 rdf:rest N002c796db21a4c10aa1523dd72e7463f
    63 N905fefd2e129415fabbc8d8a38bd647c rdf:first sg:person.01207073626.16
    64 rdf:rest Nac81ff931b834444b9d0d69fbd75c12f
    65 N9996eb34bfb348d2b3cd42c4dff044e5 schema:name Springer Nature - SN SciGraph project
    66 rdf:type schema:Organization
    67 N9e24352088564ee68cb375554d8b6bb1 schema:name readcube_id
    68 schema:value 8eb185d40be34b140c0fa8a43972ebb08454d1d6f03d9a82d6305c5ab5f4edfd
    69 rdf:type schema:PropertyValue
    70 Nac81ff931b834444b9d0d69fbd75c12f rdf:first sg:person.01132037561.53
    71 rdf:rest rdf:nil
    72 Nb1560380ada54f7e8919574c28a603b2 schema:name nlm_unique_id
    73 schema:value 101705789
    74 rdf:type schema:PropertyValue
    75 Nc04ce3c9811c464da929624cc47d98de schema:affiliation https://www.grid.ac/institutes/grid.28046.38
    76 schema:familyName Smith
    77 schema:givenName Rachel
    78 rdf:type schema:Person
    79 Nc2fb8aa82d46407a873438beb37d608c schema:affiliation https://www.grid.ac/institutes/grid.28046.38
    80 schema:familyName Pantis
    81 schema:givenName Ioana
    82 rdf:type schema:Person
    83 Nca7760f7b148466599bf0bb402359d34 schema:affiliation https://www.grid.ac/institutes/grid.28046.38
    84 schema:familyName Danik
    85 schema:givenName Marie Évelyne
    86 rdf:type schema:Person
    87 Nd55d5a1d8eff4dfb9a40e73634e35ce8 schema:name doi
    88 schema:value 10.1186/s41256-016-0020-9
    89 rdf:type schema:PropertyValue
    90 Nd59706caf9ab4677b3113e6824aa1ae4 schema:name dimensions_id
    91 schema:value pub.1029953235
    92 rdf:type schema:PropertyValue
    93 anzsrc-for:16 schema:inDefinedTermSet anzsrc-for:
    94 schema:name Studies in Human Society
    95 rdf:type schema:DefinedTerm
    96 anzsrc-for:1606 schema:inDefinedTermSet anzsrc-for:
    97 schema:name Political Science
    98 rdf:type schema:DefinedTerm
    99 sg:grant.4639944 http://pending.schema.org/fundedItem sg:pub.10.1186/s41256-016-0020-9
    100 rdf:type schema:MonetaryGrant
    101 sg:journal.1158561 schema:issn 2397-0642
    102 schema:name Global Health Research and Policy
    103 rdf:type schema:Periodical
    104 sg:person.01132037561.53 schema:affiliation https://www.grid.ac/institutes/grid.38142.3c
    105 schema:familyName Hoffman
    106 schema:givenName Steven J.
    107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132037561.53
    108 rdf:type schema:Person
    109 sg:person.011661644235.07 schema:affiliation https://www.grid.ac/institutes/grid.28046.38
    110 schema:familyName Rogers Van Katwyk
    111 schema:givenName Susan
    112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011661644235.07
    113 rdf:type schema:Person
    114 sg:person.01207073626.16 schema:affiliation https://www.grid.ac/institutes/grid.38142.3c
    115 schema:familyName Røttingen
    116 schema:givenName John-Arne
    117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207073626.16
    118 rdf:type schema:Person
    119 sg:pub.10.1007/978-3-642-61250-3_4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010599777
    120 https://doi.org/10.1007/978-3-642-61250-3_4
    121 rdf:type schema:CreativeWork
    122 sg:pub.10.2165/00148365-200605010-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019763979
    123 https://doi.org/10.2165/00148365-200605010-00007
    124 rdf:type schema:CreativeWork
    125 https://doi.org/10.1016/j.idc.2011.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032659367
    126 rdf:type schema:CreativeWork
    127 https://doi.org/10.1016/s0140-6736(15)00470-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044110610
    128 rdf:type schema:CreativeWork
    129 https://doi.org/10.1016/s0140-6736(15)00668-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043844175
    130 rdf:type schema:CreativeWork
    131 https://doi.org/10.1016/s1473-3099(16)30341-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045408017
    132 rdf:type schema:CreativeWork
    133 https://doi.org/10.1017/s0020818300027697 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012806935
    134 rdf:type schema:CreativeWork
    135 https://doi.org/10.1111/jlme.12253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014964713
    136 rdf:type schema:CreativeWork
    137 https://doi.org/10.1111/jlme.12268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030271475
    138 rdf:type schema:CreativeWork
    139 https://doi.org/10.1111/jlme.12269 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025989615
    140 rdf:type schema:CreativeWork
    141 https://doi.org/10.1111/jlme.12272 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000410078
    142 rdf:type schema:CreativeWork
    143 https://doi.org/10.1111/jlme.12275 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028362199
    144 rdf:type schema:CreativeWork
    145 https://doi.org/10.1111/jlme.12277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022284653
    146 rdf:type schema:CreativeWork
    147 https://doi.org/10.1177/003335491212700103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078511221
    148 rdf:type schema:CreativeWork
    149 https://doi.org/10.1177/175797590200900401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075281027
    150 rdf:type schema:CreativeWork
    151 https://doi.org/10.1371/journal.pmed.0030001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017489919
    152 rdf:type schema:CreativeWork
    153 https://doi.org/10.2471/blt.15.153171 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008045128
    154 rdf:type schema:CreativeWork
    155 https://doi.org/10.2471/blt.15.158998 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034639063
    156 rdf:type schema:CreativeWork
    157 https://doi.org/10.3201/eid0402.980204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029666390
    158 rdf:type schema:CreativeWork
    159 https://www.grid.ac/institutes/grid.28046.38 schema:alternateName University of Ottawa
    160 schema:name Global Strategy Lab, Centre for Health Law, Policy & Ethics, Faculty of Law, University of Ottawa, Ottawa, Canada
    161 School of Epidemiology, Public Health, and Preventive Medicine, University of Ottawa, Ottawa, Canada
    162 rdf:type schema:Organization
    163 https://www.grid.ac/institutes/grid.38142.3c schema:alternateName Harvard University
    164 schema:name Department of Clinical Epidemiology & Biostatistics and McMaster Health Forum, McMaster University, Hamilton, ON, Canada
    165 Department of Global Health & Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA
    166 Department of Health and Society, University of Oslo, Oslo, Norway
    167 Division of Infection Control & Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
    168 Global Strategy Lab, Centre for Health Law, Policy & Ethics, Faculty of Law, University of Ottawa, Ottawa, Canada
    169 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...